OpenFilings
PharmaCyte Biotech, Inc.
Form
8-K
Report Period
2026-03-30
Date Filed
2026-04-02
Time Filed
16:19:59
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
FORM 8-K
2022 INCENTIVE STOCK PLAN, AS AMENDED
Filing on SEC Edgar